Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552
Lee, J.Y.; Rozek, L.F.; Sanner, J.H.; Radzialowski, F.M.
Methods and Findings in Experimental and Clinical Pharmacology 5(4): 235-249
1983
ISSN/ISBN: 0379-0355 PMID: 6888086 Document Number: 219651
Document emailed within 1 workday
Related Documents
Morita, T.; Fukuda, T.; Sukamoto, T.; Tajima, S.; Sato, I.; Ikeda, Y.; Kanazawa, T.; Hamada, Y.; Morimoto, Y.; Kitamura, H.; Kawakami, K.; Ito, K.; Nose, T. 1982: General pharmacology of KB-944, a new calcium antagonist Arzneimittel-Forschung 32(9): 1060-1068Krivonkin, K.I.; Belousov, I.B. 1991: Clinical pharmacology of nisoldipine, a new calcium antagonist Kardiologiia 31(9): 100-105
Cerutti, C.; Su, D.F.; Barrès, C.; Paultre, C.Z.; Sassard, J. 1984: Computerized analysis of cardiovascular activity in the conscious unrestrained rat. Application to the study of a new antihypertensive agent Archives des Maladies du Coeur et des Vaisseaux 77(11): 1167-1171
Paraskos, J.A. 1986: Cardiovascular pharmacology. III: Atropine, calcium, calcium blockers, and beta-blockers Circulation 74(6 Part 2): Iv86-Iv89
Yamada, S.; Matsuoka, Y.; Kato, Y.; Kimura, R.; Inagaki, O. 1992: A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 262(2): 589-594
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401
Matsuda, S. 1991: Protective effects of calcium antagonist (nitrendipine) on calcium ionophore A23187-induced liver cell injury Bulletin of Tokyo Medical and Dental University 38(3): 35-44
Mezey, K.C. 1974: Pharmacology of antihypertensive agents Schweizerische Rundschau für Medizin Praxis 63(20): 612-617
Akashi, A.; Chiba, T.; Suzuki, I.; Hashimoto, H. 1978: Pharmacology of budralazine, a new antihypertensive drug Archives Internationales de Pharmacodynamie et de Therapie 235(1): 134-146
Greeff, K. 1975: Pharmacology of modern antihypertensive agents Die Medizinische Welt 26(10): 413-416
Rahn, K.H. 1983: Clinical pharmacology of the newer antihypertensive agents Der Internist 24(3): 128-134
Roesler, J.M.; McCafferty, J.P.; DeMarinis, R.M.; Matthews, W.D.; Hieble, J.P. 1986: Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat Journal of Pharmacology and Experimental Therapeutics 236(1): 1-7
Dickerson, L.M.; Carek, P.J. 2002: Are new antihypertensive agents better than old antihypertensive agents in preventing cardiovascular complications? Journal of Family Practice 51(1): 9
Cohen, M.L.; Fuller, R.W.; Kurz, K.D.; Parli, C.J.; Mason, N.R.; Meyers, D.B.; Smallwood, J.K.; Toomey, R.E. 1988: Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067 Journal of Pharmacology and Experimental Therapeutics 244(1): 106-112
Upward, J.W.; Arnold, B.D.; Link, C.; Pierce, D.M.; Allen, A.; Tasker, T.C. 1990: The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist European Journal of Cancer 26(Suppl 1): S12-S15
Oates, H.F. 1979: Verapamil as an antihypertensive agent New Zealand Medical Journal 89(630): 142-143
Trenkwalder, P. 2002: Is one antihypertensive agent as good as another? MMW Fortschritte der Medizin 144(45): 41-42
Poizot, A.; Dumez, D.; Ferrandon, P.; Lefournier, C.; Michel, A.; Armstrong, J.M. 1986: Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline Arzneimittel-Forschung 36(4): 695-702
Brittain, R.T.; Daly, M.J. 1981: A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist Scandinavian Journal of Gastroenterology. Suppl 69: 1-9